83 FR 18316 - Meeting of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 83, Issue 81 (April 26, 2018)

Page Range		18316-18317
FR Document		2018-08803

As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that a meeting is scheduled to be held for the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (Advisory Council). The meeting will be open to the public; a public comment session will be held during the meeting. Pre-registration is required for members of the public who wish to attend the meeting and who wish to participate in the public comment session. Individuals who wish to attend the meeting and/or send in their public comment via email should send an email to [email protected] Registration information is available on the website http://www.hhs.gov/ash/carb/ and must be completed by May 9, 2018; all in-person attendees must pre-register by this date. Additional information about registering for the meeting and providing public comment can be obtained at http://www.hhs.gov/ash/carb/ on the Meetings page.

Federal Register, Volume 83 Issue 81 (Thursday, April 26, 2018)

[Federal Register Volume 83, Number 81 (Thursday, April 26, 2018)]
[Notices]
[Pages 18316-18317]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-08803]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Presidential Advisory Council on Combating 
Antibiotic-Resistant Bacteria

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that a meeting is scheduled to be held for the Presidential Advisory 
Council on Combating Antibiotic-Resistant Bacteria (Advisory Council). 
The meeting will be open to the public; a public comment session will 
be held during the meeting. Pre-registration is required for members of 
the public who wish to attend the meeting and who wish to participate 
in the public comment session. Individuals who wish to attend the 
meeting and/or send in their public comment via email should send an 
email to [email protected]. Registration information is available on the 
website http://www.hhs.gov/ash/carb/ and must be completed by May 9, 
2018; all in-person attendees must pre-register by this date. 
Additional information about registering for the meeting and providing 
public comment can be obtained at http://www.hhs.gov/ash/carb/ on the 
Meetings page.

DATES: The meeting is scheduled to be held on May 16, 2018, from 9:00 
a.m. to 4:45 p.m. ET (times are tentative and subject to change). The 
confirmed times and agenda items for the meeting will be posted on the 
website for the Advisory Council at http://www.hhs.gov/ash/carb/ when 
this information becomes available. Pre-registration for attending the 
meeting in person is required to be completed no later than May 9, 
2018; public attendance at the meeting is limited to the available 
space.

ADDRESSES: U.S. Department of Health and Human Services, Hubert H. 
Humphrey Building, Great Hall, 200 Independence Avenue SW, Washington, 
DC 20201.
    The meeting can also be accessed through a live webcast on the day 
of the meeting. For more information,

FOR FURTHER INFORMATION CONTACT: Jomana Musmar, Acting Designated 
Federal Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S. 
Department of Health and Human Services, Room 715H, Hubert H. Humphrey 
Building, 200 Independence Avenue, SW, Washington, DC 20201. Phone: 
(202) 690-5566; email: [email protected].

SUPPLEMENTARY INFORMATION: Under Executive Order 13676, dated September 
18, 2014, authority was given to the Secretary of HHS to establish the 
Advisory Council, in consultation with the Secretaries of Defense and 
Agriculture. Activities of the Advisory Council are governed by the 
provisions of Public Law 92-463, as amended (5 U.S.C. App.), which sets 
forth standards for the formation and use of federal advisory 
committees.
    The Advisory Council will provide advice, information, and 
recommendations to the Secretary of HHS regarding programs and policies 
intended to support and evaluate the implementation of Executive Order 
13676, including the National Strategy for Combating Antibiotic-
Resistant Bacteria and the National Action Plan for Combating 
Antibiotic-Resistant Bacteria. The Advisory Council shall function 
solely for advisory purposes.
    In carrying out its mission, the Advisory Council will provide 
advice, information, and recommendations to the Secretary regarding 
programs and policies intended to preserve the effectiveness of 
antibiotics by optimizing their use; advance research to develop 
improved methods for combating antibiotic resistance and conducting 
antibiotic stewardship; strengthen surveillance of antibiotic-resistant 
bacterial infections; prevent the transmission of antibiotic-resistant 
bacterial infections; advance the development of rapid point-of-care 
and agricultural diagnostics; further research on new treatments for 
bacterial infections; develop alternatives to antibiotics for 
agricultural purposes; maximize the dissemination of up-to-date 
information on the appropriate and proper use of antibiotics to the 
general public and human and animal healthcare providers; and improve 
international coordination of efforts to combat antibiotic resistance.
    The May 16, 2018, public meeting will be focused on the topic of 
antibiotic stewardship for animal and plant health. The meeting agenda 
will be posted on the Advisory Council website at http://www.hhs.gov/ash/carb/ when it

[[Page 18317]]

has been finalized. All agenda items are tentative and subject to 
change.
    Public attendance at the meeting is limited to the available space. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the Advisory Council at the address/telephone number listed 
above at least one week prior to the meeting. For those unable to 
attend in person, a live webcast will be available. More information on 
registration and accessing the webcast can be found at http://www.hhs.gov/ash/carb/.
    Members of the public will have the opportunity to provide comments 
prior to the Advisory Council meeting by emailing [email protected]. Public 
comments should be sent in by midnight May 9, 2018, and should be 
limited to no more than one page. All public comments received prior to 
May 9, 2018, will be provided to Advisory Council members; comments are 
limited to two minutes per speaker.

    Dated: April 19, 2018.
Jomana F. Musmar,
Acting Designated Federal Officer, Presidential Advisory Council on 
Combating Antibiotic-Resistant Bacteria Committee Manager.
[FR Doc. 2018-08803 Filed 4-25-18; 8:45 am]
 BILLING CODE 4150-44-P

18316 Federal Register / Vol. 83, No. 81 / Thursday, April 26, 2018 / Notices

during the fiscal year. A copy of the Dated: April 19, 2018. FOR FURTHER INFORMATION CONTACT:
report will be provided to the Don Wright, Jomana Musmar, Acting Designated
Department’s Committee Management Deputy Assistant Secretary for Health Federal Officer, Presidential Advisory
Officer. (Disease Prevention and Health Promotion). Council on Combating Antibiotic-
Nominations. Nominations, including [FR Doc. 2018–08797 Filed 4–25–18; 8:45 am] Resistant Bacteria, Office of the
BILLING CODE 4150–32–P Assistant Secretary for Health, U.S.
self-nominations, of individuals who
Department of Health and Human
have the specified expertise and
Services, Room 715H, Hubert H.
knowledge will be considered for Humphrey Building, 200 Independence
DEPARTMENT OF HEALTH AND
appointment as members of the HUMAN SERVICES Avenue, SW, Washington, DC 20201.
Commission. A nomination should Phone: (202) 690–5566; email: CARB@
include, at a minimum, the following Meeting of the Presidential Advisory hhs.gov.
for each nominee: (1) A letter of Council on Combating Antibiotic-
nomination that clearly states the name SUPPLEMENTARY INFORMATION: Under
Resistant Bacteria
and affiliation of the nominee, the basis Executive Order 13676, dated
AGENCY: Office of the Assistant September 18, 2014, authority was given
for the nomination, and a statement
Secretary for Health, Office of the to the Secretary of HHS to establish the
from the nominee that indicates that the
Secretary, Department of Health and Advisory Council, in consultation with
individual is willing to serve as a the Secretaries of Defense and
member of the Commission, if selected; Human Services.
ACTION: Notice.
Agriculture. Activities of the Advisory
(2) a one-page biography that describes Council are governed by the provisions
the nominee’s qualifications and, if of Public Law 92–463, as amended (5
SUMMARY: As stipulated by the Federal
applicable, highlights relevant U.S.C. App.), which sets forth standards
Advisory Committee Act, the
experience on other federal advisory for the formation and use of federal
Department of Health and Human
committees; (3) the nominator’s name, Services (HHS) is hereby giving notice advisory committees.
address, and daytime telephone that a meeting is scheduled to be held The Advisory Council will provide
number; and the address, telephone for the Presidential Advisory Council on advice, information, and
number, and email address of the Combating Antibiotic-Resistant Bacteria recommendations to the Secretary of
individual being nominated; and (4) a (Advisory Council). The meeting will be HHS regarding programs and policies
current copy of the nominee’s open to the public; a public comment intended to support and evaluate the
curriculum vitae or resume, which session will be held during the meeting. implementation of Executive Order
should be limited to no more than 30 Pre-registration is required for members 13676, including the National Strategy
pages. Incomplete nomination packages of the public who wish to attend the for Combating Antibiotic-Resistant
will not be reviewed. meeting and who wish to participate in Bacteria and the National Action Plan
the public comment session. Individuals for Combating Antibiotic-Resistant
Every effort will be made to ensure
who wish to attend the meeting and/or Bacteria. The Advisory Council shall
that the composition of the Commission function solely for advisory purposes.
includes individuals from various send in their public comment via email
should send an email to CARB@hhs.gov. In carrying out its mission, the
geographic locations, including rural Advisory Council will provide advice,
and underserved areas; racial and ethnic Registration information is available on
the website http://www.hhs.gov/ash/ information, and recommendations to
minorities; genders, and persons living the Secretary regarding programs and
carb/ and must be completed by May 9,
with disabilities. Individuals other than policies intended to preserve the
2018; all in-person attendees must pre-
officers or employees of the United effectiveness of antibiotics by
register by this date. Additional
States government being considered for information about registering for the optimizing their use; advance research
appointment as members of the meeting and providing public comment to develop improved methods for
Commission will be required to can be obtained at http://www.hhs.gov/ combating antibiotic resistance and
complete and submit a report of their ash/carb/ on the Meetings page. conducting antibiotic stewardship;
financial holdings. An ethics review strengthen surveillance of antibiotic-
DATES: The meeting is scheduled to be
must be conducted to ensure that resistant bacterial infections; prevent
held on May 16, 2018, from 9:00 a.m. to the transmission of antibiotic-resistant
individuals appointed as members of
4:45 p.m. ET (times are tentative and bacterial infections; advance the
the Commission are not involved in any subject to change). The confirmed times
activity that may pose a potential development of rapid point-of-care and
and agenda items for the meeting will be agricultural diagnostics; further research
conflict of interest for the official duties posted on the website for the Advisory
that are to be performed. This is a on new treatments for bacterial
Council at http://www.hhs.gov/ash/ infections; develop alternatives to
federal ethics requirement that must be carb/ when this information becomes
satisfied upon entering the position and antibiotics for agricultural purposes;
available. Pre-registration for attending maximize the dissemination of up-to-
annually throughout the established the meeting in person is required to be date information on the appropriate and
term of appointment on the completed no later than May 9, 2018; proper use of antibiotics to the general
Commission. public attendance at the meeting is public and human and animal
Authority: The National Clinical Care limited to the available space. healthcare providers; and improve
Commission Act (Pub. L. 115–80) requires ADDRESSES: U.S. Department of Health international coordination of efforts to
amozie on DSK30RV082PROD with NOTICES

establishment of the National Clinical Care and Human Services, Hubert H. combat antibiotic resistance.
Commission. The Commission is governed by Humphrey Building, Great Hall, 200 The May 16, 2018, public meeting
provisions of the Federal Advisory Independence Avenue SW, Washington, will be focused on the topic of antibiotic
Committee Act, Public Law 92–463, as DC 20201. stewardship for animal and plant
amended (5 U.S.C. App.), which sets forth The meeting can also be accessed health. The meeting agenda will be
standards for the formation and use of federal through a live webcast on the day of the posted on the Advisory Council website
advisory committees. meeting. For more information, at http://www.hhs.gov/ash/carb/ when it

VerDate Sep<11>2014 16:58 Apr 25, 2018 Jkt 244001 PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 E:\FR\FM\26APN1.SGM 26APN1

Federal Register / Vol. 83, No. 81 / Thursday, April 26, 2018 / Notices 18317

has been finalized. All agenda items are the 21st Century Cures Act. The tickbornedisease/meetings/index.html
tentative and subject to change. subcommittees are: before submitting a request to do so via
Public attendance at the meeting is 1. Disease Vectors, Surveillance and email at tickbornedisease@hhs.gov.
limited to the available space. Prevention (includes epidemiology of Requests to provide in-person comment
Individuals who plan to attend and tick-borne diseases); are due on or before May 10, 2018. In-
need special assistance, such as sign 2. Pathogenesis, Transmission, and person comments will be limited to
language interpretation or other Treatment; three minutes each to accommodate as
reasonable accommodations, should 3. Testing and Diagnostics (including many speakers as possible. If more
notify the Advisory Council at the laboratory-based diagnoses and clinical- requests are received than can be
address/telephone number listed above diagnoses); accommodated, speakers will be
at least one week prior to the meeting. 4. Access to Care Services and randomly selected. The nature of the
For those unable to attend in person, a Support to Patients; comments will not be considered in
live webcast will be available. More 5. Vaccine and Therapeutics; and making this selection. Public comments
information on registration and 6. Other Tick-Borne Diseases and Co- may also be provided in writing.
accessing the webcast can be found at infections. Individuals who would like to provide
http://www.hhs.gov/ash/carb/. DATES: May 15, 2018, from 9:00 a.m. to written comment should review
Members of the public will have the 7:45 p.m. Eastern Time and May 16, directions at https://www.hhs.gov/ash/
opportunity to provide comments prior 2018, from 9:00 a.m. to 5:30 p.m. advisory-committees/tickbornedisease/
to the Advisory Council meeting by Eastern Time. meetings/index.html before sending
emailing CARB@hhs.gov. Public ADDRESSES: Hilton Crystal City their comments to tickbornedisease@
comments should be sent in by Conference Center at Washington hhs.gov on or before May 10, 2018.
midnight May 9, 2018, and should be Reagan National Airport, 2399 Jefferson Background and Authority: The Tick-
limited to no more than one page. All Davis Highway, Arlington, VA 22202. Borne Disease Working Group was
public comments received prior to May Members of the public may also attend established on August 10, 2017, in
9, 2018, will be provided to Advisory the meeting via webcast. Instructions for accordance with section 2062 of the 21st
Council members; comments are limited attending the meeting via webcast will Century Cures Act, and the Federal
to two minutes per speaker. be posted one week prior to the meeting Advisory Committee Act, 5 U.S.C. App.,
Dated: April 19, 2018. at: https://www.hhs.gov/ash/advisory- as amended, to provide expertise and
Jomana F. Musmar,
committees/tickbornedisease/ review all HHS efforts related to tick-
index.html. borne diseases to help ensure
Acting Designated Federal Officer,
Presidential Advisory Council on Combating FOR FURTHER INFORMATION CONTACT: interagency coordination and minimize
Antibiotic-Resistant Bacteria Committee James Berger, Office of HIV/AIDS and overlap, examine research priorities,
Manager. Infectious Disease Policy, Office of the and identify and address unmet needs.
[FR Doc. 2018–08803 Filed 4–25–18; 8:45 am] Assistant Secretary for Health, In addition, the Working Group will
BILLING CODE 4150–44–P Department of Health and Human report to the Secretary and Congress on
Services; via email at tickbornedisease@ their findings and any recommendations
hhs.gov or by phone at 202–795–7697. for the federal response to tick-borne
DEPARTMENT OF HEALTH AND SUPPLEMENTARY INFORMATION:
disease prevention, treatment and
HUMAN SERVICES In-person attendance at the meeting is research, and addressing gaps in those
limited to space available; therefore, areas.
Meeting of the Tick-Borne Disease preregistration for public members is Dated: April 19, 2018.
Working Group advisable and can be accomplished by James Berger,
AGENCY: Office of HIV/AIDS and registering at http://events.r20. Alternate Designated Federal Officer, Office
Infectious Disease Policy, Office of the constantcontact.com/register/event?llr= of HIV/AIDS and Infectious Disease Policy,
Assistant Secretary for Health, Office of zz7zptzab&oeidk=a07edrodfu088eae0cf Tick-Borne Disease Working Group.
the Secretary, Department of Health and by Thursday, May 10, 2018. On the day [FR Doc. 2018–08786 Filed 4–25–18; 8:45 am]
Human Services. of the meeting, seating will be provided BILLING CODE 4150–28–P
ACTION: Notice. first to persons who have preregistered.
People who have not preregistered will
SUMMARY: The Department of Health and be accommodated on a first come, first DEPARTMENT OF HEALTH AND
Human Services (HHS) announces the served basis if additional seats are still HUMAN SERVICES
fifth in-person meeting of the Tick- available 10 minutes before the meeting
Borne Disease Working Group (Working start. Non-U.S. citizens who plan to National Institutes of Health
Group) on May 15–16, 2018, from 9:00 attend in person are required to provide
a.m. to 7:45 p.m. Eastern Time on May Center for Scientific Review; Notice of
additional information and must notify
15 and from 9:00 a.m. to 5:30 p.m. Closed Meetings
the Working Group support staff via
Eastern Time on May 16. For this fifth email at tickbornedisease@hhs.gov Pursuant to section 10(d) of the
meeting, the Working Group will before April 30, 2018. Federal Advisory Committee Act, as
provide an overview of the report to the The Working Group invites public amended, notice is hereby given of the
HHS Secretary and Congress and comment on issues related to the following meetings.
discuss what should be included in the Working Group’s charge. It may be The meetings will be closed to the
amozie on DSK30RV082PROD with NOTICES

report from the work of the six provided in-person at the meeting or in public in accordance with the
Subcommittee Working Groups that writing. In-person comments will occur provisions set forth in sections
were established on December 12, 2017. from 9:05 a.m. to 10:05 a.m. on May 16, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
These subcommittees were established 2018. Persons who wish to provide as amended. The grant applications and
to assist the Working Group with the public comment in person should the discussions could disclose
development of the report to Congress review directions at https://www.hhs. confidential trade secrets or commercial
and the HHS Secretary as required by gov/ash/advisory-committees/ property such as patentable material,

VerDate Sep<11>2014 16:58 Apr 25, 2018 Jkt 244001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\26APN1.SGM 26APN1

Document Created: 2018-11-02 08:20:13
Document Modified: 2018-11-02 08:20:13

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice.
Dates		The meeting is scheduled to be held on May 16, 2018, from 9:00 a.m. to 4:45 p.m. ET (times are tentative and subject to change). The confirmed times and agenda items for the meeting will be posted on the website for the Advisory Council at http://www.hhs.gov/ash/carb/ when this information becomes available. Pre-registration for attending the meeting in person is required to be completed no later than May 9, 2018; public attendance at the meeting is limited to the available space.
Contact		Jomana Musmar, Acting Designated Federal Officer, Presidential Advisory Council on Combating Antibiotic- Resistant Bacteria, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services, Room 715H, Hubert H. Humphrey Building, 200 Independence Avenue, SW, Washington, DC 20201. Phone: (202) 690-5566; email: [email protected]
FR Citation		83 FR 18316